TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nakamura Läkarkonsult AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
175
|
245 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
22
|
245 | |
| EBITDA |
22
|
245 | |
| Total assets |
184
|
0 | |
| Current assets |
184
|
0 | |
| Current liabilities |
22
|
0 | |
| Equity capital |
163
|
250 | |
| - share capital |
4
|
5 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency | 88.6% | ||
| Turnover per employee |
58
|
82 | |
| Profit as a percentage of turnover |
12.6%
|
100% | |
| Return on assets (ROA) | 12.0% | ||
| Current ratio | 836.4% | ||
| Return on equity (ROE) |
13.5%
|
98.0% | |
| Change turnover |
-61
|
71 | |
| Change turnover % |
-10%
|
-26%
|
41% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
200% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.